ARTICLE | Finance
Kailera, obesity play with China roots, upsizes IPO, putting it among biggest ever: Public Equity Report
Plus: Tools company Alamar lists on NASDAQ as queue swells; Revolution’s massive follow-on; and more
April 17, 2026 9:18 PM UTC
Kailera raised $625 million late Thursday in what could soon become the largest biotech IPO ever on NASDAQ, strengthening the company’s balance sheet as it moves toward late-stage milestones for a therapy it believes could be best-in-disease.
Shares of Kailera Therapeutics Inc. (NASDAQ:KLRA) gained 63% on Friday, lifting its market cap above $3.3 billion in afternoon trading...